Republicans Turn Their Backs On Califf
Executive Summary
A visual comparison of Robert Califf’s US FDA Commissioner confirmation votes in 2016 and 2022.
You may also be interested in...
Mifepristone Access Imperiled By Supreme Court’s Draft Decision Overturning Abortion Rights
Clinicians in states that ban abortion could face criminal prosecution for providing mifepristone. Access to medical abortion ‘is not a panacea’ if the court overrules Roe v. Wade as people using the drug face risks from aggressive prosecutors, ACLU attorney says.
Califf Clears First Senate Hurdle, But FDA Abortion Pill Decision May Complicate Final Confirmation
Republican opposition to Califf over the agency’s recent move to relax its Mifeprex restrictions is ominous since in order be confirmed as FDA commissioner he’ll need enough GOP votes to make up for Democratic opposition over his opioid track record and connections to the drug industry.
Withdraw Califf FDA Nomination, Sanders Demands
Citing close ties to the biopharmaceutical industry and a lack of commitment to lowering drug prices, Sen. Bernie Sanders (I-VT) on Jan. 26 demanded President Barack Obama withdraw his nomination of Robert Califf to lead the FDA.